The layoff filings say clinical research is fine. They are wrong.

We went through the public WARN record for the clinical research industry so you do not have to. The Worker Adjustment and Retraining Notification Act requires US employers to file advance notice of large layoffs, and those filings are public. The striking finding is not what they contain. It is what they leave out.

The clinical CROs are nearly invisible

Pull the filings for the companies that actually run trials and the record is almost empty. IQVIA, the largest CRO on earth, has a single notable WARN notice on the aggregated record: 232 people at its Durham, North Carolina office, filed in August 2021 and effective that October. Parexel's record shows three filings, all between 2015 and 2019, the most recent affecting three people in San Diego. There is nothing recent, despite employee reviews describing Parexel layoffs as an annual event. Syneos, Medpace, and ICON's trial-services arms are similarly thin to absent.

If you read only the WARN record, you would conclude the clinical research industry has barely cut anyone in years. Everyone who works in it knows that is false.

The filings that do exist are the wrong companies

The fat WARN records in drug development belong to the physical side of the business, not the trial side. Charles River Laboratories, a preclinical and manufacturing company rather than a clinical CRO, has filed 16 notices covering 785 people since 2014, including repeated rounds at its Wilmington, Massachusetts headquarters through late 2025 and 2026 and a cell therapy site closure in Hanover, Maryland. Thermo Fisher, which owns the clinical CRO PPD inside a much larger instruments and bioproduction conglomerate, has filed 47 notices for 2,345 people since 2002, with recent cuts in Carlsbad, California, Alachua, Florida, and Massachusetts.

Read those locations. They are labs, plants, and bioproduction sites. They are buildings. WARN is very good at catching layoffs that happen in a building.

Why clinical work slips through

Clinical research is the opposite of a building. The workforce is remote, distributed across many states, and increasingly international. WARN generally triggers only when a single site cuts 50 or more people, or a company cuts 500 or more at once. A CRO that trims four CRAs in one state, six data managers in another, and a dozen more overseas can shed a hundred people without any single filing ever tripping the threshold. Rolling reductions handled as internal RIFs, and staff outside the US entirely, do not appear either. The reported cuts at legacy PPD in data management and clinical operations are exactly this shape: real, widely discussed, and largely absent from the clean public record.

So the near-empty WARN record for the clinical CROs does not mean the cuts are not happening. It means the cuts take a form the law was not built to capture.

What this means for you

Two practical things. First, do not take a quiet WARN record as reassurance about your employer. For a distributed clinical workforce, WARN silence is the default even during heavy cutting. Absence of evidence is not evidence of absence here; it is the expected reading.

Second, the early-warning signals that actually work for clinical research are not the filings. They are hiring freezes, unbackfilled departures, quiet program cancellations, and contractor non-renewals, none of which generate a public document. The only record of those is the people they happen to.

That is the gap this community exists to close. The government record shows the buildings. It cannot show the remote CRA whose contract was not renewed or the data management team that was quietly thinned. If that has been your year, post it, without naming individuals, and add your compensation datapoint while you are here. On this subject, you are not the anecdote. You are the data the filings are missing.